Clinical Virology Programs

Karger A, Romain CA, Vezina HE, Holman CJ, Balfour HH Jr. Clinical application of real-time quantitative Epstein-Barr virus (EBV) polymerase chain reaction assay to posttransplant infection. To be presented at the 47th annual meeting of the Infectious Diseases Society of America, Philadelphia, PA, October 30, 2009.

Vezina HE, Balfour HH Jr, Weller DR, Anderson BJ, Brundage RC. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis. J. Clin Pharmacol.

Balfour HH Jr, Vezina HE, Hogquist KA, Brundage RC, Anderson BJ, Odumade OA. Randomized, placebo-controlled, double-blind trial of valomaciclovir (VALM) for infectious mononucleosis. Presented at the 49th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 14, 2009. Abstract V1256a. In: 49th ICAAC Final Program, p221.

Weller D, Balfour HH Jr, Vezina HE. Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) in human plasma using high performance liquid chromatography. Biomed Chromatogr 2009;23:822-7.

For more detailed information please email Dr. Balfour at balfo001@umn.edu.